Poly(Adenosine diphosphate-ribose) polymerase inhibitors in cancer treatment
about
Phase 1 dose-escalation study of the PARP inhibitor CEP-9722 as monotherapy or in combination with temozolomide in patients with solid tumors.Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cellsComprehensive Analysis of ETS Family Members in Melanoma by Fluorescence In Situ Hybridization Reveals Recurrent ETV1 Amplification.Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model.The Sound of Silence: RNAi in Poly (ADP-Ribose) ResearchA pharmacokinetic evaluation of topotecan as a cervical cancer therapy.The Elephant and the Blind Men: Making Sense of PARP Inhibitors in Homologous Recombination Deficient Tumor Cells.Advances in PARP inhibitors for the treatment of breast cancer.An Aqueous Extract of Tuberaria lignosa Inhibits Cell Growth, Alters the Cell Cycle Profile, and Induces Apoptosis of NCI-H460 Tumor CellsThe PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2'-deoxycytidine lesions.STAT3 but Not HIF-1α Is Important in Mediating Hypoxia-Induced Chemoresistance in MDA-MB-231, a Triple Negative Breast Cancer Cell Line.Lowering Expectations with Niacin Treatment for CKD-MBD.[BRCA diagnostics of ovarian cancer : Molecular tumor testing since the introduction of PARP inhibitor therapy].
P2860
Q33954553-D918FF62-5E72-4193-B338-658A6919E765Q34221822-4DE3B513-7749-4E8A-9C01-BF1792FB1D5EQ37060942-3CC1985C-7554-4132-B5BA-821B96062C17Q37217995-1C0C48E3-57F2-494F-AACD-581B2809ADBEQ37508170-BE6F0600-E8E0-4709-B8C3-3257B7DD46F8Q38074207-D9A34255-8D07-45E4-B2FF-1C6395FCE33AQ38142158-A14E5901-B20A-4C25-AA19-669754171559Q38612128-533D2C28-AC65-4CD0-BAC0-6F9B71E45BB7Q38771974-0F34932B-98A2-4BD1-9ECD-7B0260C41AACQ38970507-10C4E199-2644-41C7-ABAA-FCD2DED277AAQ43499055-DD845932-5E8C-4B98-B085-D49A69CAD19CQ50059026-844B59AC-5740-4781-AA96-E0D8DCBBBBD7Q53465543-399B231F-5BAA-452F-B3C9-32297F2A94F7
P2860
Poly(Adenosine diphosphate-ribose) polymerase inhibitors in cancer treatment
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Poly(Adenosine diphosphate-ribose) polymerase inhibitors in cancer treatment
@ast
Poly(Adenosine diphosphate-ribose) polymerase inhibitors in cancer treatment
@en
type
label
Poly(Adenosine diphosphate-ribose) polymerase inhibitors in cancer treatment
@ast
Poly(Adenosine diphosphate-ribose) polymerase inhibitors in cancer treatment
@en
prefLabel
Poly(Adenosine diphosphate-ribose) polymerase inhibitors in cancer treatment
@ast
Poly(Adenosine diphosphate-ribose) polymerase inhibitors in cancer treatment
@en
P2860
P1476
Poly(Adenosine diphosphate-ribose) polymerase inhibitors in cancer treatment
@en
P2093
Alice Chen
Sook Ryun Park
P2860
P304
649-70, ix
P356
10.1016/J.HOC.2012.02.012
P577
2012-06-01T00:00:00Z